Skip to main content

Pharma News


Clinical courses


Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP,

    Glenmark has received final approval by the United States Food and Drug Administration USFDA for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), determined by the FDA to be bioequivalent1 to Nexium.
  • Risk of death from COVID-19 lessens, but infection still can cause issues 3 years later

    New findings on long COVID long-term effects on health experienced by many who have had COVID-19 present a good-news, bad-news situation, according to a study at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system.

  • Researchers take step toward development of universal COVID-19 antibodies

    SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical Research Institute (Texas Biomed), the University of Alabama at Birmingham (UAB) and Columbia University have developed a promising new human monoclonal antibody that appears a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2.

  • Antioxidant gel preserves islet function after pancreas removal
    Before surgeons remove the pancreas from patients with severe, painful chronic pancreatitis, they first harvest insulin-producing tissue clusters, called islets, and transplant them into the vasculature of the liver. The goal of the transplant is to preserve a patient’s ability to control their own blood-glucose levels without insulin injections.
  • Google wants to index your DNA
    A new DNA search tool, akin to a Google for genetic material, shows great potential, as reported by its Swiss creators. In a groundbreaking study, they managed to index 10 percent of the globes known DNA, RNA, and protein sequences, suggesting that this approach could feasibly expand to encompass the entirety of biological sequence data.
  • Torrent Pharmaceuticals to market Vonoprazan of Takeda in India
    Torrent Pharmaceuticals has entered into a non-exclusive patent licensing agreement with Takeda to commercialize Vonoprazan in India.
  • Rare Disease DNA-Damaging Mutation could have consequences for more common conditions
    TREX1 is a gene that is supposed to direct the maintenance of the entire body DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a deadly rare disease called retinal vasculopathy with cerebral leukoencephalopathy
  • Oral insulin drops offer relief for diabetes patients
    Pre-clinical tests showed that insulin with the peptide effectively reaches the bloodstream whereas without the peptide, insulin remains stuck in the inside lining of the mouth.
  • Researchers develops novel antibody treatment for Kidney Cancer
    Antibody therapies called bispecific T cell engagers have emerged as effective treatments for some blood cancers but have been more difficult to develop for solid tumors. While clinically successful, first-generation BTEs suffer a short half-life.
  • U.S. Drug-related infant deaths more than doubled in five years
    A new study by Florida Atlantic Universitys Schmidt College of Medicine has uncovered a disturbing trend in drug-related infant deaths in the United States from 2018 to 2022.
Subscribe to Pharma News